After more than ten years' experience, Qingdao Hailier Pharmaceutical Co., Ltd., Qingdao Oddis Biotechnology Co., Ltd., Qingdao Kaiyuan Xiang Chemical Co., Ltd., Shandong Hailier Chemical Co., Ltd., Jiangxi Haikeruite Crop Science Co., Ltd. and other subsidiaries have been established successively. They have five large production bases, namely Chengyang Industrial Park, Laixi Water-based Industrial Park, Laixi Jison Industrial Park, Weifang Binhai Economic Development Zone Chemical Industrial Park and Jiangxi Fengxin Industrial Park, with an annual production capacity of 5,000 tons of APIs and 20,000 tons of preparations.
Qingdao Hailier Pharmaceutical Group Co., Ltd. is the undertaker of the National "863" Plan, the National Torch Plan and the National "Twelfth Five-Year" Science and Technology Support Plan, and has six authorized invention patents. Qingdao Hailier Pharmaceutical Group Co., Ltd. is a national high-tech enterprise. The R&D Center of the Group is the enterprise technology center recognized by the state, and the trademark "Will" is recognized as a well-known trademark in China.